Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jan Lycke

Professor, adjungerad

Jan Lycke
Professor, adjungerad
jan.lycke@gu.se
+46 31-342 9047
0733-109149

Postal Address: Gröna stråket 11, plan 3, 41345 Göteborg
Visiting Address: Neurosjukvården, Gröna stråket 11, plan 3, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Department of Clinical Neuroscience at Institute of Neuroscience and Physiology (More Information)
Box 430
405 30 Göteborg
Visiting Address: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Latest publications

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
M. Boremalm, A. Juto, Markus Axelsson, Lenka Novakova, T. Frisell et al.
European Journal of Neurology, Journal article 2019
Journal article

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies
Markus Axelsson, N. Dubuisson, Lenka Novakova, Clas Malmeström, G. Giovannoni et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl, Ingrid Kockum, Mohsen Khademi, Kaj Blennow, Jan Lycke et al.
Multiple Sclerosis Journal, Journal article 2018
Journal article

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos, Amit Bar-Or, Bruce A.C. Cree, Robert J. Fox, Gavin Giovannoni et al.
The Lancet, Journal article 2018
Journal article

Showing 21 - 30 of 67

2016

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: Randomized RECYCLINE study
P. S. Sørensen, F. Sellebjerg, Jan Lycke, M. Färkkilä, A. Créange et al.
European Journal of Neurology, Journal article 2016
Journal article

Rituximab in multiple sclerosis
J. Salzer, R. Svenningsson, P. Alping, Lenka Novakova, A. Björck et al.
Neurology, Journal article 2016
Journal article

Country breakout session highlights
A. Ghezzi, L. Filli, C. Solaro, C. Mekies, L. Landete et al.
Neurodegenerative Disease Management, Conference paper 2016
Conference paper

Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29
C. Gasperini, R. Hupperts, Jan Lycke, C. Short, M. McNeill et al.
Journal of the Neurological Sciences, Journal article 2016
Journal article

Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
P. Alping, T. Frisell, Lenka Novakova, P. Islam-Jakobsson, J. Salzer et al.
Annals of Neurology, Journal article 2016
Journal article

2015

Age-dependent effects on the treatment response of natalizumab in MS patients
H. Matell, Jan Lycke, A. Svenningsson, C. Holmen, M. Khademi et al.
Multiple Sclerosis Journal, Journal article 2015
Journal article

Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis
Maria Kneider, Vera Lisovskaja, Jan Lycke, Clas Malmeström, Johannes Jakobsen et al.
Neuroepidemiology, Journal article 2015
Journal article

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle, G. Disanto, R. Dobson, R. Adiutori, L. Bianchi et al.
Multiple Sclerosis Journal, Journal article 2015
Journal article

Showing 21 - 30 of 67

Page Manager: Katinka Almrén|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?